Leco (Michigan, USA) will support the new West Coast Metabolomics Center, based at the University of California, Davis, Genome Center (California, USA).
Leco (Michigan, USA) will support the new West Coast Metabolomics Center, based at the University of California, Davis, Genome Center (California, USA). The center was opened on 8th October 2012, with funding of $9.3 million from the National Institute of Health and Disease.
Directed by Oliver Fiehn, Professor of Molecular and Cellular Biology at UC Davis, the center aims to advance research into understanding and developing treatments for diseases including diabetes, cancer and atherosclerosis using metabolomics. Metabolism differs from person to person and different dosage levels for drugs are required. As part of this support, Leco will provide access to liquid chromatography-high resolution time-of-flight mass spectrometry (LC–HR–TOF) instrumentation.
“This partnership demonstrates LECO’s renewed commitment to the advancement of metabolomics,” said Dr. Jeff Patrick, Director of Marketed Technology, LECO Separation Science. Patrick added that Leco were honoured that Dr. Fiehn and his team chose Leco instrumentation for the West Coast Metabolomics Center and his company was excited about the implications their research will have on the treatment of certain diseases.
For more information, please visit:
www.leco.com
Targeted Blood Lipidomics of Colorectal Cancer: An HTC-18 Interview with Jef Focant
July 26th 2024At HTC-18 in Leuven, Executive Editor of LCGC International, Alasdair Matheson, spoke to Jef Focant from the University of Liege about his talk entitled, “Targeted Blood Lipidomics of Colorectal Cancer."
Carol Robinson Awarded 2024 Lifetime Achievement European Inventor Award
July 24th 2024Carol Robinson of the University of Oxford has received the European Inventor Award 2024 for Lifetime Achievement from the European Patent Office for her work bringing mass spectrometry to structural biology.